PhoreMost
Life Sciences • East of England • Growth
PhoreMost’s SITESEEKER® platform enables the inception of First-in-class drug discovery programmes. Using this unique approach, PhoreMost is developing an internal asset pipeline in oncology and other diseases of ageing.
Additionally, PhoreMost is engaged in SITESEEKER collaborations with Pharma and Biotech across multiple therapeutic areas.
Company
information
Total BGF investment
£8.5m
Investment date
Mar 2021
Head office
Cambridgeshire
Chair
Chris Torrance